Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@RubenSebas_ Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::326106274.png) @RubenSebas_ Ruben Sebastian

Ruben Sebastian posts on X about $kymr, oral, $dyn, stocks the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::326106274/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::326106274/c:line/m:interactions.svg)

- X Week XXX +23,900%
- X Year XXXXX -XX%

### Mentions: X [#](/creator/twitter::326106274/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::326106274/c:line/m:posts_active.svg)


### Followers: XXX [#](/creator/twitter::326106274/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::326106274/c:line/m:followers.svg)

- X Week XXX +0.24%
- X Month XXX +0.49%
- X Year XXX -XXXX%

### CreatorRank: undefined [#](/creator/twitter::326106274/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::326106274/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  [stocks](/list/stocks) 

**Social topic influence**
[$kymr](/topic/$kymr) #44, [oral](/topic/oral), [$dyn](/topic/$dyn), [stocks](/topic/stocks), [strong](/topic/strong), [public](/topic/public), [mos](/topic/mos), [$pfe](/topic/$pfe), [$nvo](/topic/$nvo), [$mtsr](/topic/$mtsr)

**Top accounts mentioned or mentioned by**
[@caixacr](/creator/undefined) [@josealbertold](/creator/undefined) [@naturecancer](/creator/undefined) [@irbbarcelona](/creator/undefined) [@vhio](/creator/undefined) [@corinaamormd](/creator/undefined) [@mskcc](/creator/undefined) [@amorlab](/creator/undefined) [@cshl](/creator/undefined) [@melikelak](/creator/undefined) [@amgen](/creator/undefined) [@mountsinainyc](/creator/undefined) [@novartis](/creator/undefined) [@nrgtherapeutics](/creator/undefined) [@cedricblanpain](/creator/undefined) [@anqidong18](/creator/undefined) [@naturerevcancer](/creator/undefined) [@lauralorenzo](/creator/undefined) [@naturecomms](/creator/undefined)

**Top assets mentioned**
[Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Pfizer, Inc. (PFE)](/topic/$pfe) [Novo-Nordisk (NVO)](/topic/$nvo) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr)
### Top Social Posts
Top posts by engagements in the last XX hours

"$KYMR announces positives results from Ph1b of KT-621 (oral STAT6 degrader) in atopic derm. Ph2b in AD is ongoing and expansion to asthma expected in 1Q26. Shares jumped XX% in premarket. Oral therapies with biologics-like activity are becoming a reality"  
[X Link](https://x.com/RubenSebas_/status/1998050702552191015)  2025-12-08T15:23Z XXX followers, XXX engagements


"Great news reported today from X of my #portfolio companies: $KYMR (+107% last X mos) and $DYN (+63% same period). Stocks are trading well on strong clinical redouts with public markets now rewarding good data. You can own stocks into clinical catalysts and be compensated for it"  
[X Link](https://x.com/RubenSebas_/status/1998061126270255398)  2025-12-08T16:04Z XXX followers, XXX engagements


"Paramount launches a hostile takeover bid for Warner Bros Discovery worth $XXXXX billion. It seems that the recent competitive bid in biopharma between $PFE and $NVO for $MTSR has served as an early Christmas inspiration for some CEOs"  
[X Link](https://x.com/RubenSebas_/status/1998072748157944136)  2025-12-08T16:50Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@RubenSebas_ Avatar @RubenSebas_ Ruben Sebastian

Ruben Sebastian posts on X about $kymr, oral, $dyn, stocks the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX +23,900%
  • X Year XXXXX -XX%

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

  • X Week XXX +0.24%
  • X Month XXX +0.49%
  • X Year XXX -XXXX%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence finance stocks

Social topic influence $kymr #44, oral, $dyn, stocks, strong, public, mos, $pfe, $nvo, $mtsr

Top accounts mentioned or mentioned by @caixacr @josealbertold @naturecancer @irbbarcelona @vhio @corinaamormd @mskcc @amorlab @cshl @melikelak @amgen @mountsinainyc @novartis @nrgtherapeutics @cedricblanpain @anqidong18 @naturerevcancer @lauralorenzo @naturecomms

Top assets mentioned Kymera Therapeutics, Inc. Common Stock (KYMR) Dyne Therapeutics, Inc. Common Stock (DYN) Pfizer, Inc. (PFE) Novo-Nordisk (NVO) Metsera, Inc. Common Stock (MTSR)

Top Social Posts

Top posts by engagements in the last XX hours

"$KYMR announces positives results from Ph1b of KT-621 (oral STAT6 degrader) in atopic derm. Ph2b in AD is ongoing and expansion to asthma expected in 1Q26. Shares jumped XX% in premarket. Oral therapies with biologics-like activity are becoming a reality"
X Link 2025-12-08T15:23Z XXX followers, XXX engagements

"Great news reported today from X of my #portfolio companies: $KYMR (+107% last X mos) and $DYN (+63% same period). Stocks are trading well on strong clinical redouts with public markets now rewarding good data. You can own stocks into clinical catalysts and be compensated for it"
X Link 2025-12-08T16:04Z XXX followers, XXX engagements

"Paramount launches a hostile takeover bid for Warner Bros Discovery worth $XXXXX billion. It seems that the recent competitive bid in biopharma between $PFE and $NVO for $MTSR has served as an early Christmas inspiration for some CEOs"
X Link 2025-12-08T16:50Z XXX followers, XXX engagements

@RubenSebas_
/creator/twitter::RubenSebas_